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All microorganisms are exposed to periodic stresses that inhibit growth. Many bacteria and fungi weather
these periods by entering a hardy, nonreplicating state, often termed quiescence or dormancy. When this
occurs during an infection, the resulting slowly growing pathogen is able to tolerate both immune insults
and prolonged antibiotic exposure. While the stresses encountered in a free-living environment may differ
from those imposed by host immunity, these growth-limiting conditions impose common pressures, and
many of the corresponding microbial responses appear to be universal. In this review, we discuss the com-
mon features of these growth-limited states, which suggest new approaches for treating chronic infections
such as tuberculosis.A defining feature ofMycobacterium tuberculosis, the causative
agent of tuberculosis, is its slow growth. The maximal doubling
time of this bacterium is approximately 20 hr and is significantly
slower when exposed to stresses such as those encountered in
the host. Indeed, the bacterial population found in chronically in-
fected animals replicates only once every 100 hr or more (Gill
et al., 2009; Mun˜oz-Elı´as et al., 2005), and subpopulations of
bacteria are thought to cease growth entirely for significant
periods. The importance of this relatively quiescent behavior is
difficult to overstate, as it likely underlies the chronicity of the
infection as well as the requirement for extended antibiotic
therapy.
Dormancy, latency, and persistence are conceptually related
terms used to describe the propensity of M. tuberculosis to
arrest its growth in response to host-imposed stress. Because
this behavior is very different fromwell-studied model organisms
or agents of acute infection, it is sometimes considered an
unusual selective adaptation specific to the pathogenic myco-
bacteria. While this trait is likely adaptive, it is by no means
unusual. In fact, slow to negligible replication is the norm in the
microbial world, where organisms often inhabit environments
that are incompatible with rapid growth. In this review, we will
consider mycobacterial dormancy in this broader ecological
context.
Three Strategies to Weather the Storm
All microbes are subjected to changing environments, and the
basic requirements for growth (carbon, nitrogen, phosphorus,
water, etc.) are not always available. The evolutionary success
of virtually all microbial species requires the ability to weather
these periods, and the spectrum of survival strategies used by
different microbial species has been studied for decades (Stein-
haus and Birkeland, 1939). In general, these strategies can be
described as variations of three general themes (Figure 1).
Bust and Boom
The physiology of organisms that evolved in consistently
nutrient-rich environments, such as the bacteria Escherichia
coli, are tuned to maximize growth rate (Neidhardt, 1999). Undernutrient-replete conditions in which bacterial metabolism is often
studied, these organisms maximize their growth at the expense
of economy by using relatively inefficient fermentative pathways
to generate energy (Wolfe, 2005). Upon nutrient exhaustion the
majority of these bacterial populations die, leaving a few viable
organisms that subsist on the corpses of their siblings. Slow
growth and cell death are balanced during this period (Finkel,
2006). When environmental conditions become more favorable,
the few survivors resume growth. The ability to replicate rapidly
is likely to be an essential component of this strategy, as these
organisms must outcompete neighboring microbes to consume
the newly introduced nutrients.
Cellular Quiescence
A distinct strategy for surviving periods of growth-limiting stress
appears to be favored by bothM. tuberculosis (Betts et al., 2002;
Mitchison and Coates, 2004; Wayne, 1976) and many environ-
mental bacteria (Lewis and Gattie, 1991). When these organisms
are exposed to growth-limiting stress, the bulk of the bacterial
population slows or arrests its growth and can persist in a viable
nonreplicating state for months or even years (Corper and Cohn,
1933). These ‘‘quiescent’’ cells can be differentiated from truly
dormant spore-like forms because they display nominal meta-
bolic capacity, maintain their membrane potential, and do not
undergo obvious morphological differentiation (Gengenbacher
et al., 2010; Rao et al., 2008). This strategy allows the viable bac-
terial population size to be maintained throughout the period of
stress (Jones and Lennon, 2010), relieving the emphasis for rapid
growth seen in the bust-and-boom model.
True Dormancy
Sporulation is the purest form of microbial dormancy. When
exposed to growth-restricting stress, some bacteria undergo
an asymmetric cell division to produce a hardy metabolically
inactive daughter cell called a spore (Stragier and Losick,
1996). Upon exposure to favorable environmental conditions, a
fraction of spores germinate and initiate rapid growth to reestab-
lish the population. This strategy could be viewed as a combina-
tion of the first two. The spore, while fundamentally distinct,
shares many structural and biochemical features with quiescentCell Host & Microbe 13, June 12, 2013 ª2013 Elsevier Inc. 643
Figure 1. Strategies to Overcome Growth-Limiting Stress
All microorganisms encounter periods during which growth is impossible.
Three fundamental themes describe the strategies used to weather these
periods. ‘‘Bust and boom’’ describes a strategy that relies on the dynamic
persistence of a small subpopulation, ‘‘sporulation’’ is defined by the pro-
duction of metabolically inactive spores, and ‘‘quiescence’’ describes a
metabolically active nonreplicating cell that is resistant to many environmental
insults. These strategies differ in several important respects including the
population density of persistent organisms, the sensitivity of these cells to
toxins and antibiotics, and the differential dependence on rapid growth to
repopulate the niche.
Figure 2. Common Themes in Microbial Quiescence
Growth arrest can be induced by many stimuli and can have a variety of
consequences on the cell. Shown are common growth-limiting stresses
encountered by environmental microbes and pathogens. With a few notable
exceptions, most of the growth-limiting stresses encountered in these envi-
ronments are similar. Some responses to these insults are linked to a particular
stress. For example, specific DNA repair pathways are necessary to resist
oxidative and nitrosative stress, and the remodeling of carbon metabolism will
be different in hypoxic versus normoxic conditions. In contrast, other re-
sponses appear to be secondary to growth arrest per se. For example, a wide
variety of growth-inhibiting stresses trigger carbon storage and cell wall re-
modeling, and the maintenance of energy homeostasis is universally required
for viability. PMF, proton motive force; ROS, reactive oxygen species; RNI,
reactive nitrogen intermediate.
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however, rapid growth may be advantageous to repopulate the
niche. Indeed, the 10min replication time of some spore-forming
species of the clostridia bacteria are among the fastest known
(Kreidl et al., 2002).
Historically, the strategies at either end of this spectrum have
been most heavily studied. This is due to the experimental
tractability of rapidly growing organisms, not because these
strategies are more common or important. Indeed, it has been
estimated that 60% of the microbial biomass on earth exists in
a quiescent state (Cole, 1999; Lewis and Gattie, 1991). Despite
its ubiquity, we still know relatively little about the regulatory
mechanisms and physiological changes that define microbial
quiescence. While these cellular adaptations are not exactly
the same for all organisms or under all conditions, common
themes can be defined (Figure 2). In this review, we will consider
the general adaptations that are required for quiescence in
diverse microorganisms and discuss how these insights might
be used to develop more effective therapies for chronic infec-
tions such as tuberculosis.
Common Features of Quiescent Cells
Carbon Storage
An almost universal property of quiescent cells is the accumula-
tion of carbon stores, although the chemical structure of the
storage form can differ. During low growth states, the yeast
Saccharomyces cerevisiae accumulates glycogen, trehalose,
and triglycerides as the main forms of metabolizable carbon
(Gray et al., 2004). The bacterial pathogen Vibrio cholerae accu-
mulates glycogen in preparation for survival in nutrient-poor
environments (Bourassa and Camilli, 2009). Additionally, many
bacteria store fatty acids in the form of triglycerides (Daniel
et al., 2004; Kalscheuer et al., 2007) and wax esters (Sirakova
et al., 2012). Both triglycerides and wax esters also accumulate
in plant seeds (Radunz and Schmid, 2000), indicating that this
mode of storage is advantageous for organisms that represent
vastly separated domains of life. In addition, linear plastic poly-
mers like polyhydroxyalkanoates and poly-b-hydroxybutyric644 Cell Host & Microbe 13, June 12, 2013 ª2013 Elsevier Inc.acid can serve as a carbon repository in a variety of bacteria
living in the soil and the rhizosphere (Kadouri et al., 2005).
What is the purpose of carbon storage? The most intuitive
answer is that these cells are simply ‘‘storing nuts for winter,’’
and these nutritional stores can be rapidly mobilized to fuel
growth when environmental conditions improve. This role has
been most clearly demonstrated in the S. cerevisiae cell, where
the trehalose stores that accumulate in stationary cultures are
immediately consumed upon addition of freshmedia to fuel rapid
regrowth (Shi et al., 2010). Glycogen may serve a similar role in
V. cholerae, a bacterium whose life cycle relies on periodic
switches from the nutrient-replete mammalian gut to nutrient-
poor aquatic environments (Bourassa and Camilli, 2009).
Carbon storage has also been found to play an important role
in remodeling cellular carbon fluxes and facilitating entry into the
quiescent state. Diverse stresses, such as low oxygen, low pH,
or low iron, all induce a storage response in M. tuberculosis
through the activation of a common sensor-kinase system,
DosRST (Bacon et al., 2007; Baek et al., 2011; Daniel et al.,
2011). The DosS sensor likely responds to alterations in cellular
redox state in these contexts (Honaker et al., 2010), and triggers
the synthesis of triglycerides that are stored in large cytosolic
inclusions (Garton et al., 2002). The impact of this response
appears to extend beyond the generation of nutrient stores.
That is, disruption of the triglyceride biosynthesis pathway in
M. tuberculosis reverses the growth arrest that is normally
caused by these stresses, but has little effect on the subsequent
recovery of growth when the stress is relieved (Baek et al., 2011).
This inverse relationship between growth and triglyceride pro-
duction appears to result from the redirection of acetyl-CoA
from the TCA cycle, where it is used to generate energy during
aerobic respiration, into lipid synthesis, where acetyl CoA serves
as a building block for fatty acids. The growth-limiting effect of
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example, S. cerevisiae mutants that are unable to produce
glycogen or trehalose consume more CO2 than the wild-type
strain during slow growth (Sillje´ et al., 1999), indicating higher
TCA flux in the absence of carbon storage. The almost universal
propensity ofmicroorganisms to accumulate acetyl CoA-derived
carbon stores under growth-limiting stresses suggests that this
may represent a common strategy for reducing growth and
metabolic rate.
Cell Wall Modification
Virtually all bacteria are surrounded by an elastic meshwork of
peptidoglycan that maintains cellular integrity under changing
environmental conditions. This structure is composed of glycan
chains, consisting of N-acetylglucosamine (NAG) and N-acetyl-
muramic acid (NAM), crosslinked through short peptide moi-
eties. Not surprisingly, the long-term survival of both spores
and quiescent cells depends on specific alterations in the
composition of this structure. For example, in stationary phase
cultures, the Gram-positive bacteria Staphylococcus aureus
generates a cell wall that is structurally different from the pepti-
doglycan found during exponential phase growth, in that it con-
tains fewer pentaglycine bridges, which crosslink the glycan
chains, and is significantly thicker (Zhou and Cegelski, 2012).
Similarly, the level and gradient of crosslinking are important
for the formation of bacterial spores. In the spore peptidoglycan
layer of the soil-dwelling bacteria Bacillus subtilis, the peptide
side chains serving as crosslinkers are completely or partially
removed from the NAM residues and replaced by muramic-d-
lactam, a specificity determinant for germination autolytic en-
zymes, at every second NAM position in the cortex glycan
strands. As a consequence, overall levels of crosslinking are
markedly decreased in the spore cortex as compared to the
vegetative cell wall (Atrih et al., 1996). Thus, common features
of the peptidoglycan in both quiescent cells and spores are
reduced crosslinks and increased peptidoglycan mass.
The regulation of these modifications is likely complex, but
recent observations suggest that extracellular D-amino acids,
such as D-methionine and D-leucine, could play an important
role. D-amino acids accumulate to millimolar levels in the super-
natants of stationary phase bacterial culture, where they regulate
cell wall synthetic enzymes and are incorporated into the pepti-
doglycan polymer. The increased abundance of D-amino acids
in cultures of nongrowing cells and their ability to alter the
osmotic sensitivity of V. cholerae (Lam et al., 2009) suggests a
likely role in remodeling the cell wall for quiescence.
Like many other bacteria,M. tuberculosismay vary the cross-
linking of its peptidoglycan in slow growth states (Lavollay et al.,
2008). During exponential growth,M. tuberculosis peptidoglycan
is crosslinked largely via linkages between the third and fourth
amino acids in the stem peptide, the chain of amino acids in
peptidoglycan that crosslinks adjacent strands (i.e., 4/3
linkages). However, in stationary phase the cell wall primarily
consists of 3/3 crosslinks. While not all investigators have
observed these changes (Kumar et al., 2012), altered crosslink-
ing could significantly change the physical characteristics of
the cell wall. In addition, 3/3 crosslinks are made by transpep-
tidases that are insensitive to b-lactam antibiotics that inhibit cell
wall synthesis, suggesting the reduction in 4/3 linkages may
reduce antibiotic susceptibility. Indeed, when the L,D-transpep-tidase (MT2594/Rv2518c) responsible for making the 3/3 link-
ages in M. tuberculosis was inactivated, the bacteria became
more susceptible to the b-lactam antibiotic amoxicillin, and
persistence in animals was attenuated (Gupta et al., 2010).
The mycobacterial cell wall is much more complex than those
surrounding the organisms discussed above, and the full com-
plement of alterations that accompany quiescence have yet to
be defined. Mycobacterial peptidoglycan is conjugated to an
additional glycan layer and finally to a functional outermembrane
composed of very long chain fatty acids called mycolic acids.
Surrounding this hydrophobic layer is a capsule that is largely
comprised of the polysaccharide a-glucan. Thickening of the
mycobacterial cell wall upon hypoxia-induced stasis was first
demonstrated more than 30 years ago (Wayne, 1976). More
recently, a computational model of theM. tuberculosis response
to hypoxia was used to predict a large increase in production of
cell wall components like mycolic acids and peptidoglycan
(Fang et al., 2012). This prediction is consistent with electron
microscopy studies that demonstrate thickening of the outer
mycolic acid and/or capsule layers of the cell wall (Cunningham
and Spreadbury, 1998). A major physiological outcome of
these changes is decreased permeability of the cell wall,
and the uptake of several classes of antibiotics into quiescent
M. tuberculosis is significantly decreased relative to replicating
cells (Sarathy et al., 2013).
In addition to its structural roles, cell wall metabolism also
appears to play an important role in generating signals that regu-
late the germination of spores and the exit from quiescence. In
B. subtilis, the PrkC Ser/Thr kinase responds to the presence
of extracellular peptidoglycan fragments and induces spore
germination (Shah et al., 2008). These fragments are released
by growing cells, providing a mechanism by which the spore
can sense the presence of a favorable growth environment using
cues from neighboring bacteria. M. tuberculosis expresses a
similar Ser/Thr kinase, PknB, which is also capable of binding
extracellular peptidoglycan fragments (Mir et al., 2011) and reg-
ulates cell wall synthesis and growth (Gee et al., 2012). Activation
of this kinase could explain the ability of spent culture medium to
promote the regrowth of quiescent mycobacteria, as this activity
depends on secreted lysozyme-like proteins (Mukamolova et al.,
1998) that could act by liberating peptidoglycan-derived PknB
ligands.
Macromolecular Synthesis and Stability
It may seem intuitive that RNA and protein synthesis will proceed
at negligible rates in the quiescent cell. However, the dynamics
of macromolecular synthesis are more complicated than they
appear and vary during the entry, maintenance, and exit from
quiescence. During entry and exit, protein synthesis accelerates.
Protein turnover increases 5-fold in famished E. coli cells due to
proteases that are produced in early stationary phase. This
enhanced protein turnover during the transition to the growth-
limited state facilitates de novo protein synthesis in the absence
of an exogenous carbon source (Shaikh et al., 2010), and the
required amino acids are provided by peptidase-dependent
autophagy, in which amino acids are produced via protein
hydrolysis and degradation (Reeve et al., 1984). Similarly,
increased protein turnover may also be required for exiting the
quiescent state. Regrowth of M. tuberculosis from hypoxia-
induced stasis is accompanied by an increase of the ClgRCell Host & Microbe 13, June 12, 2013 ª2013 Elsevier Inc. 645
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ase that uses ATP hydrolysis to unfold proteins for subsequent
degradation (Sherrid et al., 2010). Here, increased protein turn-
over is a likely indicator of the wholesale metabolic remodeling
necessary to shift between growth states.
Once quiescence is established, however, it is reasonable to
assume that the synthesis of RNA and protein will slow consid-
erably. Indeed, quiescence in S. cerevisiae is accompanied by
a 3- to 5-fold decrease in overall transcription rate (Choder,
1991), and a 20-fold decrease in protein synthesis (Fuge et al.,
1994). The mechanisms underlying the reduction of macromo-
lecular synthesis in slowly growing E. coli have been explored
in great detail. While the rate of nascent RNA and polypeptide
chain elongation remains relatively constant, the number of syn-
thetic sites decreases (Pedersen, 1986). As approximately half of
the mass of the rapidly growing E. coli cell is comprised of pro-
tein synthesis machinery, the economy realized by this strategy
is evident (Neidhardt, 1999). The same analysis has not been
performed on nonreplicating cells, and it remains likely that
both initiation and elongation rate slow. This could be the result
of specific regulatory systems, such as the stringent response,
which controls ribosomal RNA transcription during stress (Stal-
lings et al., 2009), and is critical for M. tuberculosis survival in
both hypoxia- and starvation-induced stasis (Primm et al.,
2000). In addition, low levels of nucleotide triphosphates and
amino acids could nonspecifically limit elongation rate. This
would be consistent with the proposed mechanism by which
the drug pyrazinamide kills nonreplicating M. tuberculosis by
inhibiting trans-translation, a mechanism for recycling stalled
ribosomes (Shi et al., 2011).
The apparent reduction in RNA synthesis upon mycobacterial
entry into quiescence is coupled to a 15-fold increase in mRNA
stability (Rustad et al., 2013), and these stable mRNAs are
required to sustain pools of essential proteins (Rao and Li,
2009). This phenomenon is not unique to mycobacteria. In
both S. aureus and S. cerevisiae, mRNA transcripts are globally
stabilized in response to stationary phase and stress (Anderson
et al., 2006; Jona et al., 2000). In addition, slow growth induces
the preferential stabilization of a set of transcripts in E. coli (Geor-
gellis et al., 1993), indicating that survival requires the continual
synthesis of select proteins. In support of this model, studies
have shown that stationary phase E. coli requires the continual
expression of a subset of genes that are controlled by the sS
subunit of the RNA polymerase, including many genes in-
volved in cellular stress responses (Talukder et al., 1996). Addi-
tionally, a subset of mRNAs are strongly induced in quiescent
S. cerevisiae (Werner-Washburne et al., 1996). In sum, while
the rate of macromolecular synthesis clearly decreases in quies-
cent cells, continual transcription and translation occurs. The
ability of RNA polymerase and DNA gyrase inhibitors to kill non-
replicating mycobacteria indicates that these activities may also
be required for survival (Betts et al., 2002; Sala et al., 2010).
Energetics and Metabolism during Quiescence
Maintenance of membrane potential and ATP synthesis is not
required for sustaining the viability of spores, even though a
repertoire of ATPases and ATP-dependent regulatory proteins
is utilized during the initiation of germination (Errington, 2003).
In contrast, quiescent bacteria maintain their membrane poten-
tial (Pernthaler and Amann, 2004; Rao et al., 2008), and energy646 Cell Host & Microbe 13, June 12, 2013 ª2013 Elsevier Inc.homeostasis appears to be critical for survival. In nonreplicating
M. tuberculosis cells starved for oxygen or nutrients, ATP levels
are maintained at a steady level, which is only 5-fold lower than
replicating cells (Gengenbacher et al., 2010; Rao et al., 2008).
This maintenance of ATP homeostasis is clearly important, as
disruption of the proton motive force or chemical inhibition of
the F0F1 ATP synthase involved in ATP synthesis induces cell
death in nutrient-starved or hypoxic cultures (Rao et al., 2008;
Sala et al., 2010). Diverse strategies can be used to maintain
energy homeostasis. Both respiratory and fermentative path-
ways can support the long-term survival of bacteria in stationary
phase (Duwat et al., 2001). Similarly, M. tuberculosis harbors a
number of respiratory systems utilizing both oxygen and nitrate
as terminal electron acceptors (Boshoff and Barry, 2005).
When respiration is not possible, recent data suggest that
fermentation can lead to succinate secretion, which plays an
important role in maintaining membrane potential (Watanabe
et al., 2011; Eoh and Rhee, 2013). This general strategy is used
by a number of Gram-positive andGram-negative organisms un-
der respiration-limited conditions (Engel et al., 1994; Schnorpfeil
et al., 2001).
While the overall rate of carbon utilization decreases in quies-
cence, a few metabolic pathways display enhanced flux (Sauer
et al., 1999; Zhang et al., 2009). The specific pathways used to
maintain the quiescent cell are diverse, and their relative impor-
tance depends on the peculiarities of both the organism and the
environment. However, common themes have emerged, such as
a central role for the glyoxylate shunt in adapting to the growth-
limited state. This pathway consists of isocitrate lyase and
malate synthase and is responsible for the conversion of isoci-
trate and acetyl-CoA into malate and succinate. This bypasses
a segment of the TCA cycle that is normally siphoned to produce
biosynthetic precursors. While initially considered simply as an
anapleurotic system that is used to replenish TCA intermediates
during growth on nonglycolytic carbon sources such as lipids
(Mun˜oz-Elı´as and McKinney, 2005), recent studies indicate that
these reactions are an essential component of metabolic cycles
that sustain diverse bacterial species in slowly growing states.
The glyoxylate shunt is an essential component of the phospho-
enolpyruvate-glyoxylate cycle in E. coli (Fischer and Sauer, 2003)
and the ‘‘GAS’’ pathway in mycobacteria (Beste et al., 2011).
These pathways are important for the utilization of glucose, in
contrast to the canonical role for the glyoxylate shunt in lipid
catabolism. In both cases, these cycles are used to uncouple
glucose oxidation from the production of reducing equivalents,
and may function to maintain the redox state of the cytosol. In
the mycobacterial case, inhibition of isocitrate lyase causes
cell death in both hypoxia- and starvation-induced quiescence,
supporting the importance of these pathways in nongrowing
states (Gengenbacher et al., 2010; Eoh and Rhee, 2013).
Preservation of Genome Integrity
Maintaining genome fidelity when little or no metabolic capacity
is available for canonical DNA repair mechanisms is a challenge
faced by both quiescent cells and dormant spores. One strategy
common to both types of cells is altering chromosomal structure
to a more chemically stable form. The chromosome of stationary
phase E. coli assumes an extremely compact structure. A
nucleoid-associated protein called Dps, which is expressed
only in stationary phase, mediates biocrystallization of the
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1997). This compaction of DNA can be very dynamic as bacteria
enter and exit different growth states. In the photosynthetic
cyanobacterium, Synechococcus elongates, a circadian clock-
controlled mechanism induces periodic chromosome compac-
tion during the night (Smith andWilliams, 2006), and the resulting
alterations in DNA supercoiling control global gene expression
patterns (Vijayan et al., 2009).M. tuberculosismight use a similar
mechanism to protect its chromosome. A mycobacterial his-
tone-like protein, Lsr2, mediates chromosome compaction and
protection from reactive oxygen and nitrogen species (Summers
et al., 2012). The mechanisms underlying this protective ability
are unclear but could be related to the reported association
between Lsr2 and a FAD-binding flavoprotein thatmediates gen-
eral oxidative stress resistance (Du et al., 2012). The compact
packaging of bacterial DNA can be also facilitated by cationic
metabolites, such as polyamines, which have been implicated
in the protection of DNA from chemical damage (Baeza et al.,
1991). M. tuberculosis synthesizes a repertoire of polyamines
that facilitate transcription and DNA replication (Marton and
Pegg, 1995), although the roles of these compounds during
cellular quiescence remain unknown.
Truly dormant spores are not able to actively maintain their
chromosome but depend on the induction of DNA repair sys-
tems upon exit from the dormant state. While the nominal meta-
bolic capacity of the quiescent cell likely allows a subset of DNA
repair mechanisms to operate continuously, the relative activity
of different systems in growing and nongrowing states remains
uncertain, and distinct organisms favor different strategies.
Some microorganisms arrest growth with a single chromosome
(Valcourt et al., 2012), while others, such asM. tuberculosis, exit
the cell cycle with two chromosomal copies (Wayne, 1977).
Thus, high-fidelity recombinational repair mechanisms, which
often dominate in growing cells, are only available to a subset
of quiescent organisms. Despite the apparent presence of a
recombinational template in nonreplicating M. tuberculosis,
this organism still appears to utilize more error-prone repair sys-
tems. For example, error-prone translesion polymerases, which
replicate past DNAdamage lesions, are important for the survival
of slowly growingM. tuberculosis in chronically infected animals
(Boshoff et al., 2003). Similarly, mycobacteria rely on nonhomol-
ogous end-joining (NHEJ), in which double strand breaks are
imprecisely rejoined, to repair double-stranded breaks in quies-
cent states (Shuman and Glickman, 2007). The use of the low-
fidelity NHEJ system under these conditions could be due to
its dependence on ribonucleotides as opposed to deoxyribonu-
cleotide triphosphates, which may be limiting in nonreplicating
cells (Gong et al., 2005).
The particular DNA repair pathways used by quiescent organ-
isms have significant implications for genome evolution. While
the mutation rate of rapidly growing organisms is largely deter-
mined by the error rate of the replisome (Kunkel, 2004), the fidel-
ity of DNA repair systems might dominate in organisms that
spend a significant portion of their existence in slowly growing
states. Consistent with this model, it was recently estimated
that the M. tuberculosis genome accumulates mutations at a
similar rate in active and latent infection states (Ford et al.,
2011), and mutations accumulate in a time-dependent and not
replication-dependent manner (Ford et al., 2013). As drug resis-tance inM. tuberculosis is the product of spontaneous mutation,
the specific DNA repair pathways that are operational in the
quiescent state could determine the rate at which resistance
emerges.
Strategies to Eradicate Quiescent Bacteria
Arguably, the most important factor limiting tuberculosis control
efforts is the exceptionally long treatment course that is required
to prevent relapse. While the standard regimen of antitubercular
drugs rapidly kills replicating bacteria in vitro, the same drugs
must be administered for at least 6 months to effectively treat
an active TB infection. The reduced activity of antibiotics in the
in vivo environment is not specific to mycobacteria and is often
attributed to slowly replicating or quiescent populations of the
pathogen (Eagle, 1952; McDermott, 1958). The antibiotic sensi-
tivity of quiescent bacterial populations has been investigated
extensively in the context of environmentally induced stasis in
M. tuberculosis (Mitchison and Coates, 2004; Rao et al., 2008;
Xie et al., 2005), drug-tolerant populations found in biofilms
(Brown et al.,1988), and nonreplicating ‘‘persister’’ subpopula-
tions that exist even in rapidly growing cultures (Balaban et al.,
2004). In all situations, quiescent bacterial populations are less
sensitive to existing antibiotics that target functions necessary
for cell growth. In principle, the identification of cellular functions
that are important for the regulation or maintenance of quies-
cence should suggest new strategies for eliminating nonreplicat-
ing bacterial populations and could be used to accelerate the
treatment of chronic infections. The following three general
approaches have been pursued to this end.
Inhibit Pathways that Are Essential in the Quiescent
State
In the case of M. tuberculosis there is an anecdotal correlation
between drugs that retain activity against nonreplicating cells
in vitro and those that have the strongest sterilizing activity in vivo
(Mitchison and Coates, 2004), although this correlation is not
absolute. As a result, new drug candidates are generally tested
for their ability to kill quiescent bacteria. Among the several
new regimens under development, a combination that includes
drugs retaining activity against nonreplicating cells, bedaquiline,
PA-824, and moxifloxacin, showed the highest early bactericidal
activity in a recent human trial (Diacon et al., 2012). While none of
these drugs were developed specifically to kill in a growth rate-
independent manner, all three might have been predicted to
have this ability based on their mechanism of action. Bedaquiline
inhibits the F0F1 ATP synthase, a function required for energy
maintenance (Andries et al., 2005), PA-824 is a nitroimidazole
that kills via nonspecific nitrosative (nitrogen radical-mediated)
damage (Singh et al., 2008), and moxifloxacin produces DNA
breaks at sites of ongoing transcription (Drlica et al., 2008).
These observations suggest that specifically targeting other
functions necessary for survival, such as those maintaining
carbon flux, energy generation, or redox maintenance, might
represent a productive strategy to produce more effective ther-
apies (Table 1).
Sensitize the Quiescent Cell to Existing Antibiotics
As an alternative to targeting what is likely a restricted set of
pathways that are necessary for maintaining viability in the
absence of replication, it may also be possible to alter the
physiology of the quiescent cell to render it more antibioticCell Host & Microbe 13, June 12, 2013 ª2013 Elsevier Inc. 647
Table 1. Strategies to Eradicate Quiescent Bacterial Populations
Pathways that May Be Essential during
Quiescence Known Drugs/Inhibitors References
RNA synthesis Rifampin Betts et al., 2002; Mitchison and Coates, 2004
Proton motive force/ATP generation Bedaquiline, possibly pyrazinamide Gengenbacher et al., 2010; Rao et al., 2008;
Zhang et al., 2003
DNA gyrase/DNA integrity Fluorquinolones Hussain et al., 2009; Sala et al., 2010
Trans-translation Pyrazinamide Mitchison and Coates, 2004; Shi et al., 2011
Cell wall remodeling Carbapenem Hugonnet et al., 2009
Glyoxylate shunt None Beste et al., 2011; Mun˜oz-Elı´as and McKinney,
2005
Reductive TCA branch None Eoh and Rhee, 2013; Watanabe et al., 2011
Strategies to Resensitize Quiescent Cells Examples References
Inhibit stringent response Increases antibiotic sensitivity in P. aeruginosa
biofilm
Nguyen et al., 2011
Modulate toxin/antitoxin systems Determines the proportion of quiescent cells
in a population
Lewis, 2007
Enhance antibiotic uptake Metabolite supplementation increases
aminoglycoside uptake
Allison et al., 2011
Impose nonspecific nitrosative damage Nitromidazoles (e.g., Metronatazole, PA-824,
Delamanid)
Singh et al., 2008
Enhance TCA activity Sensitizes to multiple antibiotics Baek et al., 2011; Kohanski et al., 2007
Strategies to Remove Quiescence-
Inducing Cues
References
Biofilm dispersion Disrupts starvation-induced quiescence Potera, 2010
TNF modulation Enhances anti-TB therapy Bourigault et al., 2013
Immunosuppression Accelerates antibacterial therapy in animal models Assfalg et al., 2010; Lenaerts et al., 2003
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biotic activity by altering flux through central carbonmetabolism.
In M. tuberculosis, antibiotic efficacy is reduced as a result of
carbon storage responses that lower TCAflux.Geneticmutations
or nutritional supplements that inhibit triglycerideproduction, and
thus drive activity of the TCA cycle, or directly enhance TCA flux
were found to enhance antibiotic activity in quiescent cells in vitro
and in animal models (Baek et al., 2011). A similar approach for
enhancing TCA-dependent antibiotic activity by metabolite sup-
plementation was subsequently found to enhance aminoglyco-
side activity in E. coli and S. aureus (Allison et al., 2011). Another
promising approach is inhibiting the stringent response. This
systemcoordinates cellular physiologyduring slowgrowth states
in many bacteria, and genetic inhibition of the stringent response
sensitizes Pseudomonas aeruginosa biofilms to antibiotics
(Nguyen et al., 2011). While metabolite supplementation might
not be practical formany infections of the deep tissues, and small
molecule modulators of these pathways are not currently avail-
able, these studies provide proof for the concept that quiescent
cells can be rendered antibiotic susceptible.
Alter the Growth-Limiting Stress
Instead of directly modulating bacterial metabolism, it may be
possible to enhance drug efficacy by removing the specific envi-
ronmental pressures that induce quiescence. For example, non-
replicating, antibiotic-tolerant cells are found in relatively high
numbers in bacterial biofilms (Lewis, 2007), and the disruption
of the biofilm architecture increases antibiotic activity at least
in part by reversing this differentiation (Musk and Hergenrother,648 Cell Host & Microbe 13, June 12, 2013 ª2013 Elsevier Inc.2006). Similarly, it may be possible to modulate the host immune
pressures that induce the antibiotic tolerant state. Overt immu-
nosuppression can enhance antibiotic activity in a number of
models (Assfalg et al., 2010; Lenaerts et al., 2003). Even more
subtle chemical modulation of tumor necrosis factor (TNF) sig-
naling, which plays central roles in the inflammatory response,
has been shown to accelerate antituberculosis therapy in ani-
mals (Bourigault et al., 2013).
Thus, both the host and the pathogen can be manipulated to
increase antibiotic efficacy. A more detailed understanding of
the specific pressures that limit growth during infection and the
pathogen’s adaptations to these stresses could lead to the
rational development of new synergistic therapies that accel-
erate antibacterial treatment.
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